Compare Charles River Laboratories Intl. Inc (CRL) vs Sprott Uranium Miners ETF (URNM) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Charles River Laboratories Intl. Inc vs Sprott Uranium Miners ETF — how do they compare? Charles River Laboratories Intl. Inc trades at $226.39 (market cap $11.14B), while Sprott Uranium Miners ETF trades at $50.1. The key difference: Charles River Laboratories Intl. Inc is trading nearer its 52-week high, Sprott Uranium Miners ETF nearer its low. Which is the better fit depends on your goals.
| CRL | URNM | |
|---|---|---|
Market Cap | $11.14B | — |
Sector | Health | Commodities - Metals/Agriculture |
52-Week High | $233.60 | $83.99 |
52-Week Low | $145.57 | $44.14 |
Enterprise Value | $14.00B | — |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Charles River Laboratories (CRL) trades at $229.75, down 1.57% on the day, near its consensus price target of $229.80. The stock shows a bullish technical trend with strong moving average signals and support at $225. Fundamentally, CRL has beaten EPS estimates for three consecutive quarters but reported a net loss of $144.34 million in 2025, with negative profit margins. Recent news highlights collaborations in AI and NGS services, supporting growth prospects.
Outlook remains mixed: analyst consensus is strongly bullish with 72% buy ratings and a high target of $260, but profitability challenges and high P/E of 684.85 pose risks. Cash flow stability and strategic partnerships offer upside, while margin pressures and debt levels require monitoring for sustained recovery.
URNM trades at $50.21, down 5.78% over 24 hours amid bearish technical signals, with moving averages indicating strong selling pressure. The uranium ETF faces volatility despite positive sector narratives around AI-driven power demand. Financial ratios are unavailable as this is a fund holding mining equities rather than an operating company with traditional financial statements.
The long-term uranium thesis remains supported by nuclear energy's role in AI infrastructure, but near-term price action shows weakness. Concentration in miners creates higher volatility versus diversified nuclear ETFs. Key risks include uranium spot price fluctuations and miner operational performance.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
About Charles River Laboratories Intl. Inc
Charles River Laboratories was founded in 1947 and is a leading provider of drug discovery and development services. The company's research model & services segment is the leading provider of animal models for laboratory testing, which breeds and delivers animal research models with specific genetic characteristics for preclinical studies around the world. The discovery & safety assessment segment includes services required to take a drug through the early development process, including discovery services. The manufacturing support segment includes microbial solutions, which provides in vitro (non-animal) testing products, biologics testing services, and avian vaccine services.
Read more on CRL →About Sprott Uranium Miners ETF
URNM is a pure-play ETF that invests in the global uranium industry. It provides exposure to companies involved in the mining, exploration, and production of uranium, as well as physical uranium holdings, with top assets like Cameco, Uranium Energy Corp, and the Sprott Physical Uranium Trust.
Read more on URNM →
